Shenzhen New Industries Biomedical Engineering (SHE:300832) obtained two medical device registration certificates from the Guangdong Provincial Food and Drug Administration, according to a Shenzhen Stock Exchange filing on Wednesday.

The certificates are for the progesterone assay kit (magnetic particle chemiluminescence method) and the anti-glomerular basement membrane antibody IgG assay kit (magnetic particle chemiluminescence method), which are valid until Jan. 20, 2030 and Feb. 7, 2030, respectively, the Chinese biomedical technology company said.

The company's shares slid more than 2% in recent trade.